Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p10
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 10/191)
Character Range: 9549169–9560688

acids-synthetic, formula                                                                                                                                             Patient must be 18 years of age or less.
                                                                                                                                                                                                                               Treatment with oral steroids should not be commenced during the period of initial treatment.
                                                                                                                                                                                                                               Eosinophilic oesophagitis is demonstrated by the following criteria
                                                                                                                                                                                                                               (i) Chronic symptoms of reflux that persisted despite a 2-month trial of a proton pump inhibitor or chronic dysphagia; and
                                                                                                                                                                                                                               (ii) A lack of demonstrable anatomic abnormality with the exception of stricture, which can be attributable to eosinophilic oesophagitis; and
                                                                                                                                                                                                                               (iii) Eosinophilic infiltration of the oesophagus, demonstrated by oesophageal biopsy specimens obtained by endoscopy and where the most densely involved oesophageal biopsy had 20 or more eosinophils in any single 400 x high powered field, along with normal antral and duodenal biopsies.
                                                                                                                                                                                                                               The date of birth of the patient must be included in the authority application.
C4369               P4369          CN4369           Dabigatran etexilate                                                                                                                                                       Prevention of venous thromboembolism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 4369
                                                                                                                                                                                                                               Patient must be undergoing total hip replacement; AND
                                                                                                                                                                                                                               Patient must require up to 20 days supply to complete a course of treatment.
C4373               P4373          CN4373           Amlodipine with valsartan                                                                                                                                                  Hypertension
                                                                                                                                                                                                                               The treatment must not be for the initiation of anti-hypertensive therapy; AND
                                                    Olmesartan with amlodipine                                                                                                                                                 The condition must be inadequately controlled with an angiotensin II antagonist.  or
                                                                                                                                                                                                                               The condition must be inadequately controlled with a dihydropyridine calcium channel blocker.
                                                    Telmisartan with amlodipine

C4374               P4374          CN4374           Candesartan with hydrochlorothiazide                                                                                                                                       Hypertension
                                                                                                                                                                                                                               The treatment must not be for the initiation of anti-hypertensive therapy; AND
                                                    Eprosartan with hydrochlorothiazide                                                                                                                                        The condition must be inadequately controlled with an angiotensin II antagonist.  or
                                                                                                                                                                                                                               The condition must be inadequately controlled with a thiazide diuretic.
                                                    Irbesartan with hydrochlorothiazide

                                                    Olmesartan with hydrochlorothiazide

                                                    Telmisartan with hydrochlorothiazide

                                                    Valsartan with hydrochlorothiazide

C4375               P4375          CN4375           Perindopril with indapamide                                                                                                                                                Hypertension
                                                                                                                                                                                                                               The treatment must not be for the initiation of anti-hypertensive therapy; AND
                                                                                                                                                                                                                               The condition must be inadequately controlled with an ACE inhibitor.  or
                                                                                                                                                                                                                               The condition must be inadequately controlled with a thiazide-like diuretic.
C4380               P4380          CN4380           Budesonide with formoterol                                                                                                                                                 Asthma                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 4380
                                                                                                                                                                                                                               Patient must have previously had frequent episodes of asthma while receiving treatment with oral corticosteroids or optimal doses of inhaled corticosteroids; or
                                                                                                                                                                                                                               Patient must have experienced frequent asthma symptoms while receiving treatment with oral or inhaled corticosteroids and require single maintenance and reliever therapy; or
                                                                                                                                                                                                                               Patient must have experienced frequent asthma symptoms while receiving treatment with a combination of an inhaled corticosteroid and long acting beta-2 agonist and require single maintenance and reliever therapy;
                                                                                                                                                                                                                               Patient must be aged 12 years or over.
C4381               P4381          CN4381           Apixaban                                                                                                                                                                   Prevention of venous thromboembolism                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Compliance with Authority Required procedures - Streamlined Authority Code 4381
                                                                                                                                                                                                                               Patient must be undergoing total knee replacement; AND
                                                    Dabigatran etexilate                                                                                                                                                       Patient must require up to 10 days of